Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it closed the previously disclosed divestiture of its KaVo Treatment Unit & Instrument business. Envista received $317.3...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ implant system. Boasting a biologically...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced an update to the company's participation at the 40th Annual J.P. Morgan Healthcare Conference. Envista will present virtually...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Carestream Dental's Intra-Oral Scanner (IOS) business for $600 million....

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the following upcoming investor conferences: Stifel MedTech Madness 2021 Annual West...